Peptilogics is a clinical-stage biotechnology company developing a new platform technology that enables us to rapidly and effectively develop novel peptide therapeutics for unmet patient needs, with an early focus on anti-infectives.
Our therapeutics in development demonstrates the potential for powerful broad-spectrum activity against the most dangerous drug-resistant bacteria, with significantly better resistance profile...
Peptilogics is a clinical-stage biotechnology company developing a new platform technology that enables us to rapidly and effectively develop novel peptide therapeutics for unmet patient needs, with an early focus on anti-infectives.
Our therapeutics in development demonstrates the potential for powerful broad-spectrum activity against the most dangerous drug-resistant bacteria, with significantly better resistance profile and efficacy due to novel mechanisms of action.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.